Yin T, Yasukawa K, Taga T, Kishimoto T, Yang Y C
Department of Medicine (Hematology/Oncology), Walther Oncology Center, Indiana University School of Medicine, Indianapolis 46202.
Exp Hematol. 1994 May;22(5):467-72.
Interleukin-11 (IL-11) shares the common signal transducer gp130 with IL-6, leukemia inhibitory factor (LIF), and oncostatin M (OSM) and triggers activation of unknown tyrosine kinases as the early steps of signal transduction pathway. Here we identify a 130-kilodalton tyrosine-phosphorylated protein induced by IL-11 in 3T3-L1 cells as JAK2 tyrosine kinase. We further show that the in vitro kinase activity of JAK2 is greatly enhanced following stimulation with IL-11 in 3T3-L1 cells and TF-1 cells. Furthermore, we demonstrate that JAK2 physically associates with the signal transducer gp130. Similar results were observed following stimulation with IL-6, LIF, and OSM. However, we were unable to show that JAK1 is tyrosine phosphorylated and activated by IL-11 under identical conditions. These results suggest that JAK2 tyrosine kinase is one of the tyrosine kinases involved in signal transduction mediated by IL-11, IL-6, LIF, and OSM.
白细胞介素-11(IL-11)与白细胞介素-6、白血病抑制因子(LIF)和抑瘤素M(OSM)共用共同信号转导子gp130,并在信号转导途径的早期步骤中触发未知酪氨酸激酶的激活。在此,我们鉴定出在3T3-L1细胞中由IL-11诱导的一种130千道尔顿的酪氨酸磷酸化蛋白为JAK2酪氨酸激酶。我们进一步表明,在3T3-L1细胞和TF-1细胞中用IL-11刺激后,JAK2的体外激酶活性大大增强。此外,我们证明JAK2与信号转导子gp130发生物理缔合。在用IL-6、LIF和OSM刺激后观察到类似结果。然而,在相同条件下,我们未能证明JAK1被IL-11酪氨酸磷酸化并激活。这些结果表明,JAK2酪氨酸激酶是参与由IL-11、IL-6、LIF和OSM介导的信号转导的酪氨酸激酶之一。